Northpointe Bancshares, Inc.

NYSE:NPB

Banks - Regional

Financial Services
$14.79 +0.11%

+$0.02 today

Market cap
$511.47M
Beta
0.11
P/E (TTM)
3.1
EPS (TTM)
$5.85
Dividend yield
0.56%
52W Low $12.95High $19.48

Volume 0.33M

Average 0.15M

NPB EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Northpointe Bancshares, Inc.NYSE: NPB

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA grows, but more slowly than its trailing trend

Q1 FY2026 EBITDA of $30.17M rose 28.9% year over year, behind the +44.2% change in trailing-twelve-month EBITDA. Sequentially, it fell 5.6% from the prior quarter. Over 3 fiscal years it compounded at +44.4% a year.

Context

  • EBITDA amounted to 24.1% of revenue in FY2025, up 4.4 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 2 analysts of $105.3M (-7.2%) for the fiscal year ending Dec 2026, a slowdown from the +48.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$30.17M-5.6% QoQ
Last fiscal yearDec 2025
$113.47M+48.0% YoY
LTMMar 2026
$119.49M+44.2% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+28.9%+20.9%-8.0 pp
1 year+48.0%-7.2%-55.2 pp
3-year CAGR+44.4%+5.8%-38.5 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
113.47M USD
Year-over-year change
+48.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How NPB compares with its peers on the latest reported figures

  • NPB's LTM Mar 2026 EBITDA of $119.49M is the highest of the 7 companies compared; the peer median is -$134.59M.
  • Its year-over-year change of +44.2% is the 2nd highest of 7, against a peer median of +5.0%.
  • EBITDA amounts to 24.2% of revenue for NPB, versus a peer median of 37.5%.
NPB Competitors Peer median
EBITDA for NPB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NPBNorthpointe Bancshares, Inc.LTM Mar 2026$119.49M +44.2%+44.4%24.2%
LEGNLegend Biotech CorporationLTM Sep 2026$99.55M +154.3%—7.3%
ALXOALX Oncology Holdings Inc.LTM Mar 2026-$86.7M +32.0%——
CCCCC4 Therapeutics, Inc.LTM Mar 2026-$100.38M -3.7%—287.9%
ZLABZai Lab LimitedLTM Jun 2026-$168.8M +13.6%—37.5%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026-$220.73M -23.8%——
ERASErasca, Inc.LTM Sep 2026-$305.05M -151.6%——
Peer median (excluding NPB) -$134.59M+5.0%—37.5%

Competitors are the stored peer set for NPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.17M324.24M362.45M390.46M471.18M
Cost of Revenue1.14M68.9M164.68M202.99M231.56M
Gross Profit1.02M255.34M197.77M187.47M239.62M
Gross Margin47.3%78.7%54.6%48.0%50.9%
Research & Development29.88M0000
Selling, General & Admin22.17M159.88M104.29M77.79M93.62M
Operating Expenses52.05M221.65M153.08M114.59M129.23M
Depreciation & Amortization840.94K4.02M4.02M3.8M3.07M
EBITDA(56.67M)37.71M48.7M76.68M113.47M
EBITDA Margin-2613.5%11.6%13.4%19.6%24.1%
Operating Income(51.03M)33.69M44.69M72.88M110.39M
Operating Margin-2353.1%10.4%12.3%18.7%23.4%
Interest Income525.54K166.12M267.38M317.53M380.2M
Interest Expense066.69M166.16M203.32M229.47M
Other Income / Expenses(6.49M)0000
Income Before Tax(57.52M)33.69M44.69M72.88M110.39M
Pre-Tax Margin-2652.3%10.4%12.3%18.7%23.4%
Income Tax Expense(77.7K)10.46M10.93M17.72M26.98M
Net Income(57.44M)23.24M33.76M55.16M83.41M
Net Margin-2648.7%7.2%9.3%14.1%17.7%
EPS (Basic)(1.74)0.921.613.154.92
EPS (Diluted)(1.74)0.921.613.154.85
Weighted Avg Shares33.03M14.92M14.92M14.92M14.54M
Weighted Avg Shares (Diluted)33.03M14.92M14.92M14.92M14.72M

Northpointe Bancshares, Inc.

NYSE:NPB

Intrinsic Alpha fair value

Locked

Current Price

$14.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.